Patients who test positive for COVID-19 can now get the antiviral pill Paxlovid directly from their pharmacists, the U.S. Food and Drug Administration announced Wednesday.
The action removes limits that had restricted prescribing authority to health care providers and Test-to-Treat sites.
“The FDA recognizes the important role pharmacists have played and continue to play in combatting this pandemic,” Dr. Patrizia Cavazzoni, director for the FDA’s Center for Drug Evaluation and Research, said in a news release announcing the change.
